MedPath

Outcomes of Trasversus Abdominis Release for Complex Abdominal Wall Hernia

Completed
Conditions
Hernia, Abdominal
Hernia Incisional
Registration Number
NCT06111287
Lead Sponsor
Azienda Sanitaria Locale Napoli 2 Nord
Brief Summary

This multicenter retrospective study analyzed data from 308 patients who underwent open Posterior Component separation with Trasversus release for primary or recurrent complex abdominal hernias between 2015 and 2020. The primary endpoint was the rate of Hernia Recurrence and Mesh Bulging at 3, 6, 12, 24, and 36 months. Secondary outcomes included surgical site events and were assessed using the Pain scale.

Detailed Description

Study design This study is reported according to the STROBE statement for cohort studies A retrospective multicentric study was conducted to analyze the surgical outcomes of patients undergoing open with Posterior Component separation with Trasversus release for inisional hernia. It was conducted according to the ethical principles stated in the Declaration of Helsinki. Written informed consent was obtained from all subjects.

Study setting and study population From January 2015 and May 2020, all the patients affected by primary or recurrent complex abdominal hernias undergoing open Posterior Component separation with Trasversus release referring to 6 centers, were considered for enrollment in the study. Inclusion criteria were age ≥16 years, primary or recurrent complex abdominal hernias with more than \>10 cm midline defects Exclusion criteria were follow-up data lower than 36 months, patients with a stoma for whom closure was not planned during the abdominal hernia repair

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
432
Inclusion Criteria
  • age ≥16 years,
  • primary or recurrent complex abdominal hernias with more than >10 cm midline defects
Exclusion Criteria
  • follow-up data lower than 36-months, patients with a stoma for whom closure was not planned during the abdominal hernia repair

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hernia Recurrence36 months

In details, Hernia Recurrence was clinically defined as any visible or palpable ''blowout'' in the abdominal wall. computed tomography scan evaluation was carried out by a radiologist with 10 years of gastrointestinal computed tomography scan experience.

Mesh Bulging36 months

In details, Mesh Bulging was clinically defined as any visible or palpable ''blowout'' in the abdominal wall. computed tomography scan evaluation was carried out by a radiologist with 10 years of gastrointestinal computed tomography scan experience.

surgical site events1 months

Regarding the surgical site events, the classification of wound events was assigned according to the likelihood and degree of wound contamination at the time of the operation, as stated in the Centre for Disease Control and Prevention wound classification (superficial, deep or organ space)

Number of patients affected by Superficial surgical site infection1 months

Superficial infections according to Clavien-Dindo criteria

Secondary Outcome Measures
NameTimeMethod
Number of patients affected by Superficial surgical site infectionsWithin 30 days postoperatively

Superficial infections according to Clavien-Dindo criteria

Number of patients affected by organ space infectionsWithin 30 days postoperatively

Organ space infections according to Clavien-Dindo criteria

Number of patients affected by Surgical Site OccurenceWithin 30 days postoperatively

Surgical Site Occurence Reported according to the Ventral Hernia Working Group (VHWG) definitions

Number of patients affected by Deep surgical site infectionsWithin 30 days postoperatively

Deep surgical site infections according to Clavien-Dindo criteria

Postoperative painPostoperative pain will be recorded according to visual analogue scale Visual Analogue Scale at 36 month.

Postoperative pain will be recorded according to the Visual Analogue Scale (VAS). The Visual Analogue Scale (VAS) measures pain intensity. The Visual Analogue Scale consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be').

Trial Locations

Locations (2)

Francesco Pizza

🇮🇹

Naples, Italy

Francdesco Pizza

🇮🇹

Napoli, Naples, Italy

© Copyright 2025. All Rights Reserved by MedPath